San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1

Regulations
May.18.2022
San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1
San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1

The San Diego City Council officially passed an ordinance Tuesday to ban the sale of flavored tobacco products — including menthol — in the city, effective Jan. 1, 2023.

 

The move — spearheaded by Councilwoman Marni von Wilpert — follows similar actions in cities such as Imperial Beach, Encinitas and Solana Beach, along with San Diego County for unincorporated areas. It also comes months before a statewide referendum tackling the issue in November.

 

The council passed the first reading of the issue in April. This second vote makes the ordinance — known as the Stop Adolescent Addiction From E-Cigarettes or SAAFE Act — law.

 

“I thank my colleagues for standing with me to stop Big Tobacco from addicting an entire new generation of youth on tobacco products by officially approving the SAAFE Act,” von Wilpert said. 

 

“Flavored tobacco products are intentionally marketed to kids and I am proud that our city is taking action to prevent the sale of these products and protect our youth.”

 

The ordinance does not apply to the sale of shisha, premium cigars or loose-leaf tobacco and unflavored or tobacco-flavored e-cigarettes, as well as FDA-approved cessation devices that will also be exempt from the ban.

 

Councilwoman Jennifer Campbell said in her 40 years practicing medicine, she had seen the impact on children who lived in homes with smokers.

 

“We must stop Big Tobacco from aggressively targeting our children and vulnerable communities,” she said. “The Stop Adolescent Addiction From E-Cigarettes will help protect our communities from the tobacco industry making life-long customers addicted to nicotine.”

 

According to findings presented in April by von Wilpert’s office, in the most recent completed study of the city’s tobacco retailers in 2019, 14.7% of retailers sold to an underage police decoy. In a study to come, she said, those numbers have increased to nearly 30%.

 

Source:TIMESOFSANDIEGO

In opposition to the law at the lengthy public hearing in April were dozens of small business owners, who claimed flavored tobacco made up anywhere from 25% to nearly half of their business. Nearly all of them claimed they were law-abiding business owners who had been commended by the San Diego Police Department for their above-board operations. Several also decried what they called the paternalistic nature of the city council’s new law, saying parents should be in charge of how children were raised, not the government.

KT&G Launches “Miix Cigar Collection” for lil Hybrid at Convenience Stores Nationwide
KT&G Launches “Miix Cigar Collection” for lil Hybrid at Convenience Stores Nationwide
KT&G said on April 15 that it will launch “Miix Cigar Collection,” a dedicated stick for its lil Hybrid heated tobacco product, at convenience stores nationwide in South Korea. The company said the product is the first in the Miix series to apply a “Balance Filter” with internal space in the filter and contains 18% cigar leaf to deliver cigar flavor. With the new launch, the Miix lineup for lil Hybrid will expand to 16 products.
Apr.15 by 2FIRSTS.ai
China Boton Group Posts 2025 Revenue of RMB 1.496 Billion, With E-Cigarette Product Revenue Up 4.6%
China Boton Group Posts 2025 Revenue of RMB 1.496 Billion, With E-Cigarette Product Revenue Up 4.6%
China Boton Group reported its results for the year ended December 31, 2025. Revenue was RMB 1.496 billion, down about 9.5% from RMB 1.653 billion in 2024. Gross profit was RMB 377.1 million, with a gross margin of 25.2%, and the group recorded a net loss of RMB 1.000 billion for the year.
Mar.24 by 2FIRSTS.ai
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Special Report | Tax Veteran Takes Helm at China’s Tobacco Regulator, Leadership Change Fuels Reform Watch
Special Report | Tax Veteran Takes Helm at China’s Tobacco Regulator, Leadership Change Fuels Reform Watch
China’s tobacco system has appointed a new top internal leader with a long background in public finance and taxation, drawing renewed attention to whether the country’s tobacco monopoly may enter a new phase of reform debate. The appointment itself does not signal a defined policy shift.But it places a veteran fiscal official at the center of a key state sector amid unresolved questions on tax reform, structure, and emerging tobacco products.
Mar.20
Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesian Health Ministry Says New Vape Rules Will Cover Age Limits, Advertising, and Product Standards
Indonesia’s Ministry of Health is preparing to implement regulations on electronic cigarettes, as provided for in Government Regulation No. 28 of 2024. The ministry said e-cigarettes will be regulated under provisions equivalent to those applied to conventional cigarettes, including age restrictions, advertising controls, product content standards, pictorial health warnings, and bans on use in smoke-free areas.
Apr.16 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai